There was a greater fall in hepcidin levels among roxadustat-treated patients that did not reach statistical significance; the difference in the decrease in serum ferritin levels between the 2 arms also was nonsignificant.
← all excerpts
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors for the Treatment of Anemia in CKD: Additional Pieces of the Jigsaw Puzzle.
1
—
—